The world’s longest-lasting pig kidney transplant was removed from the human recipient Friday April 4th 2025, marking the end of the longest lasting xenotransplantation to date. Read More
Learn about health literacy and how it impacts patients with CKD including IgAN. Dr. Velez will share her expertise as a nephrologist treating patients with IgAN as well as discuss… Read More
This is the first guideline from KDIGO on a rare kidney disease, and provides healthcare providers, stakeholders, and people living with ADPKD with practical tools to improve diagnosis, care, and… Read More
In 2024, patients on the waiting lists for nearly 20 percent of transplants from deceased donors were skipped over in favor for someone further down the list. This is six… Read More
The National Institutes of Health (NIH) awards grants providing federal funding for research purposes, including payments for “indirect costs,” defined as “facilities” and “administration.” Previously these were negotiated indirect cost… Read More
In this episode, Dr. Thomas Weimbs discusses ketogenic diets for polycystic kidney disease (PKD), explaining the science behind ketosis and its potential impact. Read More
This webinar will explore how B-cell biology, including the role of APRIL (A Proliferation-Inducing Ligand), informs our understanding of IgAN and opens new avenues for therapeutic intervention. Read More
In this episode, renal dietitian Kelly Welsh discusses ketogenic diets for polycystic kidney disease (PKD). She explains the fundamentals of a ketogenic diet, how ketosis works, and shares strategies for… Read More
By becoming a Supporting Organization, you will receive the opportunity to:
Promote your organization’s logo and brief description to NephU’s 8,000+ members on the NephU Supporting Organizations page
Collaborate, develop, and cross promote resources and events
Submit published articles, resources, or relevant materials to the NephU Resource Library
*Note: Event postings, potential cross promotional materials, interviews, and resources are subject to the legal review process of NephU’s sponsor Otsuka Pharmaceutical Development & Commercialization, Inc (OPDC).
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the kidney health community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.